65.39
price up icon3.76%   2.37
after-market アフターアワーズ: 65.32 -0.07 -0.11%
loading
前日終値:
$63.02
開ける:
$64.06
24時間の取引高:
284.02K
Relative Volume:
0.56
時価総額:
$1.88B
収益:
$234.60M
当期純損益:
$-13.23M
株価収益率:
-125.61
EPS:
-0.5206
ネットキャッシュフロー:
$19.61M
1週間 パフォーマンス:
+1.04%
1か月 パフォーマンス:
+18.65%
6か月 パフォーマンス:
+196.69%
1年 パフォーマンス:
+254.61%
1日の値動き範囲:
Value
$64.00
$66.01
1週間の範囲:
Value
$60.92
$66.01
52週間の値動き範囲:
Value
$15.40
$68.39

Anaptysbio Inc Stock (ANAB) Company Profile

Name
名前
Anaptysbio Inc
Name
セクター
Healthcare (1114)
Name
電話
858-362-6295
Name
住所
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Name
職員
104
Name
Twitter
@anaptysbio
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
ANAB's Discussions on Twitter

Compare ANAB vs VRTX, REGN, ALNY, ARGX, INSM

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ANAB icon
ANAB
Anaptysbio Inc
65.39 1.81B 234.60M -13.23M 19.61M -0.5206
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
454.97 113.96B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
749.47 78.41B 14.34B 4.50B 3.77B 41.56
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
328.70 40.85B 3.71B 313.75M 465.38M 2.2571
ARGX icon
ARGX
Argen X Se Adr
697.05 42.05B 4.16B 1.29B 734.26M 19.58
INSM icon
INSM
Insmed Inc
148.31 29.99B 606.42M -1.28B -997.58M -6.403

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-07 再開されました UBS Buy
2025-10-13 開始されました Barclays Overweight
2025-06-04 アップグレード H.C. Wainwright Neutral → Buy
2025-02-04 開始されました Wolfe Research Outperform
2024-12-11 ダウングレード H.C. Wainwright Buy → Neutral
2024-12-02 ダウングレード BTIG Research Buy → Neutral
2024-07-22 開始されました H.C. Wainwright Buy
2024-07-19 アップグレード JP Morgan Neutral → Overweight
2024-04-16 開始されました Leerink Partners Outperform
2024-04-11 開始されました Wells Fargo Overweight
2024-03-12 アップグレード Wedbush Neutral → Outperform
2024-02-26 開始されました BTIG Research Buy
2024-02-21 開始されました Stifel Buy
2024-02-16 開始されました Piper Sandler Overweight
2023-05-22 アップグレード JP Morgan Underweight → Neutral
2023-05-18 開始されました TD Cowen Outperform
2023-01-06 ダウングレード Raymond James Outperform → Mkt Perform
2022-11-01 アップグレード Guggenheim Neutral → Buy
2022-09-19 再開されました H.C. Wainwright Buy
2022-09-13 ダウングレード Truist Buy → Hold
2022-09-01 開始されました Raymond James Outperform
2022-03-22 ダウングレード Guggenheim Buy → Neutral
2021-06-22 開始されました H.C. Wainwright Buy
2021-05-21 開始されました UBS Neutral
2021-03-16 アップグレード Truist Hold → Buy
2021-03-09 ダウングレード Wedbush Outperform → Neutral
2021-03-08 ダウングレード JP Morgan Overweight → Underweight
2021-02-11 アップグレード JP Morgan Underweight → Overweight
2020-10-27 アップグレード Wedbush Neutral → Outperform
2020-10-14 アップグレード Guggenheim Neutral → Buy
2019-11-08 ダウングレード JP Morgan Overweight → Underweight
2019-11-08 ダウングレード Jefferies Buy → Hold
2019-11-08 ダウングレード SunTrust Buy → Hold
2019-11-08 ダウングレード Wedbush Outperform → Neutral
2019-06-21 ダウングレード Credit Suisse Outperform → Neutral
2019-06-21 ダウングレード Stifel Buy → Hold
2018-12-20 開始されました H.C. Wainwright Buy
2018-11-21 開始されました JP Morgan Overweight
2018-07-19 開始されました Credit Suisse Outperform
2018-04-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2018-03-27 繰り返されました Stifel Buy
2018-03-06 繰り返されました Stifel Buy
2018-02-15 繰り返されました SunTrust Buy
2018-01-23 繰り返されました Credit Suisse Outperform
2017-11-15 開始されました SunTrust Buy
2017-11-09 開始されました Jefferies Buy
2017-10-11 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
すべてを表示

Anaptysbio Inc (ANAB) 最新ニュース

pulisher
05:57 AM

Analysis Recap: Can AnaptysBio Inc grow without external fundingRecession Risk & Weekly High Return Stock Forecasts - baoquankhu1.vn

05:57 AM
pulisher
Mar 23, 2026

Investment Report: Can AnaptysBio Inc reach all time highs this yearLong Setup & Daily Price Action Insights - baoquankhu1.vn

Mar 23, 2026
pulisher
Mar 22, 2026

RSI Check: Will AnaptysBio Inc benefit from geopolitical trends2026 Year in Review & Capital Efficient Trade Techniques - baoquankhu1.vn

Mar 22, 2026
pulisher
Mar 22, 2026

AnaptysBio (NASDAQ:ANAB) Sees Unusually-High Trading Volume – Should You Buy? - Defense World

Mar 22, 2026
pulisher
Mar 20, 2026

ANAB Stock Falls After It Sues GSK Unit Tesaro Again, Claims Fresh Breach Of 2014 Deal - MSN

Mar 20, 2026
pulisher
Mar 20, 2026

Tranche Update on AnaptysBio, Inc.'s Equity Buyback Plan announced on March 24, 2025. - marketscreener.com

Mar 20, 2026
pulisher
Mar 20, 2026

AnaptysBio (NASDAQ:ANAB) Sees Strong Trading VolumeTime to Buy? - MarketBeat

Mar 20, 2026
pulisher
Mar 18, 2026

Aug Levels: Does AnaptysBio Inc stock have upside surprise potential2026 Recap & Low Drawdown Investment Strategies - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 18, 2026

ANAB Rating Boost: UBS Raises Price Target to $90 | ANAB Stock N - GuruFocus

Mar 18, 2026
pulisher
Mar 17, 2026

UBS Group Issues Positive Forecast for AnaptysBio (NASDAQ:ANAB) Stock Price - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

UBS raises AnaptysBio stock price target to $90 on pipeline upside - Investing.com Australia

Mar 17, 2026
pulisher
Mar 17, 2026

UBS raises AnaptysBio stock price target to $90 on pipeline upside By Investing.com - Investing.com South Africa

Mar 17, 2026
pulisher
Mar 17, 2026

AnaptysBio, Inc. $ANAB Shares Purchased by Granahan Investment Management LLC - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

AnaptysBio Hits New 12-Month High - National Today

Mar 17, 2026
pulisher
Mar 17, 2026

How (ANAB) Movements Inform Risk Allocation Models - Stock Traders Daily

Mar 17, 2026
pulisher
Mar 17, 2026

AnaptysBio (NASDAQ:ANAB) Hits New 12-Month HighShould You Buy? - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

AnaptysBio stock hits 52-week high at 66.73 USD By Investing.com - Investing.com Australia

Mar 17, 2026
pulisher
Mar 16, 2026

Psoriasis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | AnaptysBio, Nimbus Lakshmi, Takeda, MoonLake Immunotherapeutics, Can-Fite Biopha - Barchart

Mar 16, 2026
pulisher
Mar 16, 2026

AnaptysBio stock hits 52-week high at 66.73 USD - Investing.com

Mar 16, 2026
pulisher
Mar 16, 2026

Adaptive Biotechnologies (ADPT) Rises 5.8%: Can This Momentum Continue? - Bitget

Mar 16, 2026
pulisher
Mar 16, 2026

First Light Asset Management Reduces Stake in AnaptysBio - National Today

Mar 16, 2026
pulisher
Mar 16, 2026

First Light Asset Management LLC Sells 2,549,432 Shares of AnaptysBio, Inc. $ANAB - MarketBeat

Mar 16, 2026
pulisher
Mar 15, 2026

ANAB SEC FilingsAnaptysbio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 15, 2026
pulisher
Mar 13, 2026

HC Wainwright & Co. Maintains AnaptysBio (ANAB) Buy Recommendation - MSN

Mar 13, 2026
pulisher
Mar 12, 2026

Aug Fed Impact: Can AnaptysBio Inc grow without external funding2026 Selloffs & Weekly Chart Analysis and Guides - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 12, 2026

AnaptysBio (ANAB): Wedbush Raises Price Target to $75 with Outpe - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

Wedbush Forecasts Strong Price Appreciation for AnaptysBio (NASDAQ:ANAB) Stock - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

Wedbush Raises Price Target on AnaptysBio to $75 From $60, Keeps Outperform Rating - marketscreener.com

Mar 12, 2026
pulisher
Mar 11, 2026

AnaptysBio Details First Tracks Bio Spin-Off, Jemperli Royalty Surge and GSK Litigation Timeline - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

AnaptysBio (NASDAQ:ANAB) Sets New 52-Week HighWhat's Next? - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

AnaptysBio Plans First Tracks Spin-Off as Jemperli Royalties Surge, Buybacks Possible - MarketBeat

Mar 11, 2026
pulisher
Mar 10, 2026

Barclays Initiates Coverage of AnaptysBio (ANAB) with Overweight Recommendation - MSN

Mar 10, 2026
pulisher
Mar 10, 2026

ANAB: Biopharma spin-off advances antibody pipeline as royalty business leverages Jemperli growth - TradingView

Mar 10, 2026
pulisher
Mar 09, 2026

ANAB: Truist Securities Maintains Hold Rating, Raises Price Targ - GuruFocus

Mar 09, 2026
pulisher
Mar 08, 2026

AnaptysBio, Inc. $ANAB Shares Sold by Citigroup Inc. - MarketBeat

Mar 08, 2026
pulisher
Mar 07, 2026

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 07, 2026
pulisher
Mar 06, 2026

AnaptysBio, Inc. Experiences Revision in Its Stock Evaluation Amid Market Trends - Markets Mojo

Mar 06, 2026
pulisher
Mar 06, 2026

Truist raises AnaptysBio stock price target to $50 on Jemperli outlook - Investing.com Canada

Mar 06, 2026
pulisher
Mar 06, 2026

Truist Adjusts Price Target on AnaptysBio to $50 From $36, Maintains Hold Rating - marketscreener.com

Mar 06, 2026
pulisher
Mar 06, 2026

What is HC Wainwright's Estimate for AnaptysBio Q1 Earnings? - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Assessing AnaptysBio (ANAB) Valuation After Profitability Turnaround And Strong Jemperli Royalty Progress - Yahoo Finance

Mar 06, 2026
pulisher
Mar 06, 2026

AnaptysBio (ANAB) Q4 Profit Of US$49.6 Million Tests Longstanding Loss-Making Narrative - Sahm

Mar 06, 2026
pulisher
Mar 06, 2026

Trading Systems Reacting to (ANAB) Volatility - Stock Traders Daily

Mar 06, 2026
pulisher
Mar 05, 2026

AnaptysBio stock hits 52-week high at 57.86 USD By Investing.com - Investing.com Nigeria

Mar 05, 2026
pulisher
Mar 05, 2026

HC Wainwright Weighs in on AnaptysBio FY2030 Earnings - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

AnaptysBio, Inc. Hits New 52-Week High of $62.69, Up 156% - Markets Mojo

Mar 05, 2026
pulisher
Mar 05, 2026

AnaptysBio Stock Soars 14.61%, Hits Intraday High of $62.69 - Markets Mojo

Mar 05, 2026
pulisher
Mar 05, 2026

AnaptysBio (NASDAQ:ANAB) Price Target Raised to $85.00 at Stifel Nicolaus - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Stifel Raises Price Target for AnaptysBio (ANAB) to $85, Reaffir - GuruFocus

Mar 05, 2026
pulisher
Mar 04, 2026

AnaptysBio stock hits 52-week high at 57.86 USD - Investing.com South Africa

Mar 04, 2026
pulisher
Mar 04, 2026

AnaptysBio Says R&D Spinout May Launch By April - Citeline News & Insights

Mar 04, 2026

Anaptysbio Inc (ANAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$27.36
price up icon 1.82%
$47.03
price up icon 3.20%
$53.54
price up icon 4.29%
$88.77
price up icon 2.26%
ONC ONC
$283.45
price up icon 2.81%
$148.31
price up icon 6.59%
大文字化:     |  ボリューム (24 時間):